Recruiting

Observational Study

Sponsor:

University of Kansas Medical Center

Code:

NCT05530408

Conditions

Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed toward identifying clinical applications of imaging methods and toward understanding the physiological significance of imaging biomarkers. This registry and biorepository will accelerate the development of these imaging techniques and may lead toward future clinical adoption of quantitative pulmonary imaging.

Conditions

Pulmonary Disease

Study ID

NCT05530408

Start date

May 24, 2022

Status verified date

Apr, 2026

Completion date

May 31, 2028

Anticipated

Primary completion date

Dec 31, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • The participant is enrolling/has enrolled in a research study at the University of Kansas Medical Center that involves Pulmonary MRI and/or Pulmonary CT.

Exclusion Criteria:

  • The participant declines to participate.

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Collect Clinical Data [ Time Frame: From Enrollment to 3 Months ]
  • Establish a Biorepository [ Time Frame: From Enrollment to 3 Months ]
  • Biospecimen Collection [ Time Frame: From Enrollment to 6 Months ]
  • Collaborate [ Time Frame: From Enrollment to 12 Months ]

Central Contacts and Locations

Central contacts

Locations

University of Kansas Medical Center

Recruiting

Kansas City, Kansas, United States, 66160

Contacts

Principal Investigator:

Peter J Niedbalski, PhD

More Information

Sponsor

University of Kansas Medical Center

Last update posted

May 6, 2026

Last verified

Apr, 2026

Keywords

  • Xenon
  • Xe-129
  • CT

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Kansas Medical Center on 2026-05-06.